Get in touch Contact us
Search Spire
Please type into the search bar above to begin your search
Please type three or more characters above to begin your search
Mr Supratik Chattopadhyay

Practicing at

Spire Leicester Hospital
Book an appointment online
Find a date that suits you
View availability
Book an appointment by phone -
0116 272 0888
We will help you arrange your appointment
Call to book
Have an enquiry?
Send an enquiry and we will contact you
Make an enquiry

An initial consultation with Mr Supratik Chattopadhyay is from £220.

Mr Supratik Chattopadhyay

Mr Supratik Chattopadhyay

Consultant Gynaecological Surgeon

MBBS, DGO, MD, FRCOG

Find next available initial appointment

Specialises in

  • Gynaecological surgery
  • Endometriosis keyhole treatment
  • Gynaecological cancer surgery
  • Diagnostics and minor procedure surgeries
  • Sees adults only at Spire Leicester Hospital

Also available for:

Virtual consultations:

I qualified in 1997, and I am a Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG). I have been practicing in Leicester for over 10 years. I am a Senior Consultant Gynaecologist and Gynaecological Oncology Surgeon, and I am highly skilled in complex open surgery for advanced gynaecological cancers as well as complex benign gynaecological conditions. I am also an advanced laparoscopic and robotic (keyhole) surgeon. I worked as a Consultant Gynaecological Oncology Surgeon at the University Hospitals of Leicester NHS Trust from January 2015 to September 2025.

My practice philosophy is to provide holistic care that meets the highest clinical standards, and I am best known for my excellent communication and thoroughness in delivering individualised care, helping my patients to make well-informed decisions.

I am a highly experienced gynaecologist, offering a wide range of services in general gynaecology, including the management of menstrual disorders, pelvic pain, menopausal problems, and the surgical treatment of endometriosis and fibroids. I also provide diagnostic gynaecology services such as colposcopy, diagnostic hysteroscopy with myosure, endometrial ablation, and both laparoscopic and robotic procedures for ovarian cysts, endometriosis, in addition to hysterectomy operations.

I also specialise in the surgical treatment of endometrial (womb) cancer, cervical cancer, ovarian cancer, and vaginal and vulval cancers. I offer sentinel lymph node mapping and excision for gynaecological cancers, along with cytoreductive surgery and pelvic exenterative surgery for advanced and recurrent gynaecological cancers.

To date, as a highly experienced Gynaecologist and Gynaecological Oncology Surgeon, I have performed over 2,000 hysterectomy operations (open, laparoscopic and robotic), and more than 5,000 diagnostic gynaecological procedures (hysteroscopy, colposcopy and laparoscopy).

Read more...

General Medical Council Number: 6111908

Treatment information

Some of the principal treatments carried out by Mr Supratik Chattopadhyay at Spire include:

Gynaecology

Other treatments

  • Advanced laparoscopic and advanced robotic surgery (Intuitive da Vinci Xi)
  • Colposcopy
  • Endometrial cancer, cervical cancer ovarian and fallopian tube cancer, vulval cancer, vaginal cancer treatment
  • Endometriosis surgery
  • Hysteroscopy and Myosure procedures

Get in touch

44978
True
consultant
Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

We will use your personal information to process your enquiry. For further information, please see our privacy policy.


Additional information

Colposcopy
Endometriosis
Gynaecology and/or obstetrics
Gynaecological cancer
Hysteroscopy
Laparoscopic surgery
Menopause
Menorrhagia
Menstrual disorders
Oncology
Post menopausal problems

Special clinical interests: Ovarian, cervical, endometrial and vulval cancer.

MBBS / University of Calcutta, India / 1997
Bachelor of Medicine, Bachelor of Surgery

DGO / Kolkata, India / 2002
Diploma in Obstetrics & Gynaecology

MD (O&G) / Kolkata, India / 2004
Doctor of Medicine in Obstetrics & Gynaecology

MRCOG / London / 2007
Member of the Royal College of Obstetricians & Gynaecologists

BSCCP / Birmingham / 2012
Colposcopy Accreditation

Subspecialist Accreditation in Gynaecological Oncology and entry to the Subspecialist Register, General Medical Council / London / 2015
Subspecialist Accreditation in Gynaecological Oncology and entry to the Subspecialist Register, General Medical Council

FRCOG / Royal College of Obstetricians & Gynaecologists / 2024
Fellow of the Royal College of Obstetricians & Gynaecologists

Professional memberships

Royal College of Obstetricians and Gynaecologists

British Society for Colposcopy and Cervical Pathology

British Gynaecological Cancer Society

  • Endometrial cancer
  • Ovarian cancer treatment
  • Cervical precancer

I am an editorial reviewer for The British Journal of Obstetrics and Gynaecology (BJOG), The European Journal of Obstetrics, Gynaecology and Reproductive Biology (EJOGRB).

Articles

Use of redundant skin as autograft in repair of incisional hernia.
July 2004

Tumour-free distance from serosa (TFD) in surgically staged (FIGO stage I-III) endometrioid endometrial cancer: is it clinically useful?
September 2011

Small volume stage 1B1 cervical cancer: Is radical surgery still necessary?
July 2012

Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer
September 2012

Small volume stage 1B1 cervical cancer: Is radical surgery still necessary?
October 2012

Temporal and generational trends of human papilloma virus (HPV) associated cancers, registered between 1985-2009, in England.
October 2012

The role of intraoperative fluid optimization using the esophageal Doppler in advanced gynecological cancer: early postoperative recovery and fitness for discharge
January 2013

Surgical cytoreduction for recurrent epithelial ovarian cancer
February 2013

Myth or Migration
April 2013

Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer
May 2013

Class of body mass index (BMI) determines aggressiveness and post-treatment survival in type I endometrial cancer
June 2013

Rare Neoplasm - Sebaceous Carcinoma of the Vulva
October 2013

Adjuvant chemotherapy does not preclude the need for pelvic +/- para-aortic lymphadenectomy in FIGO stage I - IV uterine serous cancer.
October 2013

Management of borderline change in endocervical cells - a more dependable approach
March 2014

Management of borderline change in endocervical cells: a more dependable approach
June 2014

Timing of cytoreductive surgery does not influence overall survival (OS) in FIGO stage IIIC-IV primary peritoneal papillary serous carcinoma (PPC).
July 2014

A higher prevalence of non-HPV 16/18 subtypes may lead to a higher incidence of high-grade cervical pre-cancer changes.
April 2015

Depth of loop biopsy of the cervix; Have we changed our practice?
June 2016

Impact of frailty on postoperative morbidity in elderly women undergoing laparotomy for gynaecological cancer.
June 2016

Audit on hospital based clinical follow-up for women with borderline ovarian tumours (BOT) in Leicester
July 2018

Multidisciplinary maximum effort cytoreductive surgery (MES) for advanced ovarian cancer in Leicester: (Outcomes).
July 2018

Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial
February 2021

‘’Does the mode of referral in women with ovarian cancer (OC) affect their prognosis?’’
May 2021

‘’Atypical complex endometrial hyperplasia (AEH): surgery vs. hormone, better safe than sorry’’
May 2021

‘’Rare low grade Endometroid Ovarian Cancer with metastasis: A case report.’’
May 2021

‘’Vaginal cancer in a patient with post-menopausal bleeding: a case report.’’
May 2021

‘’Recurrent Endometrial Cancer with Vaginal Metastasis: a case report.’’
May 2021

‘’ Ovarian Cancer: General Practioner (GP) compliance with NICE Guidelines’’
May 2021

Peri-operative Variables Associated With Prolonged Intensive Care Stay Following Cytoreductive Surgery for Ovarian Cancer
June 2021

Progestogen treatment in atypical complex endometrial hyperplasia; how safe is Plan B?
October 2021

Overall survival and progression free survival in IDS vs PDS in advanced ovarian cancer patients in the University Hospitals of Leicester
October 2021

Comparing patient characteristics and survival rates in ovarian cancer patients presenting from (GP) and (ED) in the University Hospitals of Leicester
October 2021

Exploring the reasons behind opting for palliative chemotherapy or no treatment in advanced ovarian cancer patients
October 2021

Exploring the reasons behind opting for palliative chemotherapy or no treatment in advanced ovarian cancer patients
October 2021

Comparing patient characteristics and survival rates in ovarian cancer patients presenting from (GP) and(ED) in the university hospitals of Leicester
October 2021

Overall survival rates and progression free survival in IDS vs PDS in advanced ovarian cancer patients in the university hospitals of Leicester
October 2021

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
February 2022

Effect of New RCOG 2019 Curriculum and COVID 19 on Gynaecological Training in the U.K
May 2022

Mode of Referral of Ovarian Cancer Patients: Does it Alter Treatment and Survival?
July 2022

The impact of the new RCOG 2019 curriculum and COVID 19 pandemic on Gynaecological training amongst the Specialist Trainees in the United Kingdom: a cross-sectional study
July 2022

Palliative chemotherapy vs no treatment in advanced ovarian cancer (AOC) patients: Reasons and benefits
July 2022

Cytoreductive surgery (CRS) for advanced ovarian cancer (AOC) in Leicester: Benefits of a paradigm shift in surgical approach in 2015.
July 2022

Endometrial Cancer Incidence in Patients With Atypical Endometrial Hyperplasia According to Mode of Management
September 2022

Management of advanced ovarian cancer in Leicester: The benefits of a paradigm shift in surgical approach
December 2022

Impact of Patient Body Mass Index on Post-Operative Recovery from Robotic-Assisted Hysterectomy
August 2023

Sentinel lymph node detection in endometrial cancer
July 2024

Robotic Surgery – Future of Gynaecology?
April 2025

I am married and enjoy travelling to exotic destinations with my wife. In my spare time I play tennis at least twice a week, enjoy cooking and fine dining, gardening and walking our toy maltipoo dog.

Website https://www.chattopadhyay.co.uk/
Private secretary Mrs Pauline Lewis
Private secretary telephone 07961 213775
Private secretary email pauline.lewis@spirehealthcare.com
How can we help?
Book online Make an enquiry